FDA Approves Generic HIV Prevention Shot to Boost Global Access
The FDA has approved a generic version of the HIV prevention drug lenacapavir, with an Indian manufacturer pledging to sell it for $40 annually in low- and middle-income countries.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
3 publishers have covered this in 4 articles since 2 Nov 2026. Latest News from Science Magazine published first, on 2 November at 05:25 UTC; STAT followed 10h 48m later. The most recent article, from MedPageToday.com - medical news for physicians, appeared on 3 November at 15:39 UTC.
Outlets reporting it: Latest News from Science Magazine (major outlet), STAT, MedPageToday.com - medical news for physicians.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
- Latest News from Science MagazineU.S. approval of cheap, generic HIV prevention shot may boost global rollout
- STATSTAT+: FDA OKs generic HIV prevention shot, widening access for lower-income countries
- STATSTAT+: Pharmalittle: We’re reading about a generic HIV prevention shot, Lonza buying U.S. facilities, and more
- MedPageToday.com - medical news for physiciansGeneric Lenacapavir Approval for HIV Prevention Raises Hope in Low-Income Nations
Sources
Every article we clustered into this story. Headlines link to the publisher.
- U.S. approval of cheap, generic HIV prevention shot may boost global rollout Latest News from Science Magazine ·
- Generic Lenacapavir Approval for HIV Prevention Raises Hope in Low-Income Nations MedPageToday.com - medical news for physicians
- STAT+: Pharmalittle: We’re reading about a generic HIV prevention shot, Lonza buying U.S. facilities, and more STAT
- STAT+: FDA OKs generic HIV prevention shot, widening access for lower-income countries STAT
In this story
- FDA
- Science Magazine